BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barca C, Griessinger CM, Faust A, Depke D, Essler M, Windhorst AD, Devoogdt N, Brindle KM, Schäfers M, Zinnhardt B, Jacobs AH. Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. Pharmaceuticals (Basel) 2021;15:13. [PMID: 35056071 DOI: 10.3390/ph15010013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hennrich U, Eder M. [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer. Pharmaceuticals 2022;15:1292. [DOI: 10.3390/ph15101292] [Reference Citation Analysis]
2 Espino-vázquez AN, Rojas-castro FC, Fajardo-yamamoto LM. Implications and Practical Applications of the Chemical Speciation of Iodine in the Biological Context. Future Pharmacology 2022;2:377-414. [DOI: 10.3390/futurepharmacol2040026] [Reference Citation Analysis]
3 Ahenkorah S, Murce E, Cawthorne C, Ketchemen JP, Deroose CM, Cardinaels T, Seimbille Y, Fonge H, Gsell W, Bormans G, Ooms M, Cleeren F. 3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals. Theranostics 2022;12:5971-85. [PMID: 35966589 DOI: 10.7150/thno.75336] [Reference Citation Analysis]
4 Holik HA, Ibrahim FM, Elaine AA, Putra BD, Achmad A, Kartamihardja AHS. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker. Molecules 2022;27:3062. [PMID: 35630536 DOI: 10.3390/molecules27103062] [Reference Citation Analysis]
5 Peserico A, Di Berardino C, Russo V, Capacchietti G, Di Giacinto O, Canciello A, Camerano Spelta Rapini C, Barboni B. Nanotechnology-Assisted Cell Tracking. Nanomaterials 2022;12:1414. [DOI: 10.3390/nano12091414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Qu Y, Wang Z, Sun M, Zhao T, Zhu X, Deng X, Zhang M, Xu Y, Liu H. A Theranostic Nanocomplex Combining with Magnetic Hyperthermia for Enhanced Accumulation and Efficacy of pH-Triggering Polymeric Cisplatin(IV) Prodrugs. Pharmaceuticals (Basel) 2022;15:480. [PMID: 35455477 DOI: 10.3390/ph15040480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]